Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of rRNA.


Autoria(s): Aellen S.; Que Y.A.; Guignard B.; Haenni M.; Moreillon P.
Data(s)

2006

Resumo

Assessing bacterial viability by molecular markers might help accelerate the measurement of antibiotic-induced killing. This study investigated whether rRNA could be suitable for this purpose. Cultures of penicillin-susceptible and penicillin-tolerant (Tol1 mutant) Streptococcus gordonii were exposed to mechanistically different penicillin and levofloxacin. Bacterial survival was assessed by viable counts and compared to quantitative real-time PCR amplification of either the 16S rRNA genes or the 16S rRNA, following reverse transcription. Penicillin-susceptible S. gordonii lost > or =4 log(10) CFU/ml of viability over 48 h of penicillin treatment. In comparison, the Tol1 mutant lost < or =1 log(10) CFU/ml. Amplification of a 427-bp fragment of 16S rRNA genes yielded amplicons that increased proportionally to viable counts during bacterial growth but did not decrease during drug-induced killing. In contrast, the same 427-bp fragment amplified from 16S rRNA paralleled both bacterial growth and drug-induced killing. It also differentiated between penicillin-induced killing of the parent and the Tol1 mutant (> or =4 log(10) CFU/ml and < or =1 log(10) CFU/ml, respectively) and detected killing by mechanistically unrelated levofloxacin. Since large fragments of polynucleotides might be degraded faster than smaller fragments, the experiments were repeated by amplifying a 119-bp region internal to the original 427-bp fragment. The amount of 119-bp amplicons increased proportionally to viability during growth but remained stable during drug treatment. Thus, 16S rRNA was a marker of antibiotic-induced killing, but the size of the amplified fragment was critical for differentiation between live and dead bacteria.

Identificador

http://serval.unil.ch/?id=serval:BIB_ADA6EA5A0802

isbn:0066-4804[print], 0066-4804[linking]

pmid:16723545

doi:10.1128/AAC.00869-05

isiid:000237932200001

Idioma(s)

en

Fonte

Antimicrobial Agents and Chemotherapy, vol. 50, no. 6, pp. 1913-1920

Palavras-Chave #Anti-Bacterial Agents/pharmacology; Colony Count, Microbial; DNA, Bacterial/genetics; DNA, Bacterial/isolation & purification; Genes, Bacterial; Genetic Markers; Kinetics; Microbial Sensitivity Tests; Mutation; Ofloxacin/pharmacology; Penicillins/pharmacology; Polymerase Chain Reaction; RNA, Bacterial/analysis; RNA, Bacterial/genetics; RNA, Ribosomal/analysis; RNA, Ribosomal/chemistry; RNA, Ribosomal, 16S/analysis; RNA, Ribosomal, 16S/chemistry; Streptococcus/drug effects; Streptococcus/genetics
Tipo

info:eu-repo/semantics/article

article